The present experiment was designed to examine the effects of hypothyroidism and calcineurin inhibition induced by cyclosporin-A (CsA) administration on both contractile and metabolic soleus muscle phenotypes, with a novel approach to the signaling pathway controlling mitochondrial biogenesis. Twenty-eight rats were randomly assigned to four groups: normothyroid or hypothyroid, and orally treated with either CsA (25 mg.kg^-1, N-CsA and H-CsA), or vehicle (N-Vh and H-Vh) for three weeks. Muscle phenotype was estimated by the MHC profile and activities of oxidative and glycolytic enzymes. We measured mRNA levels of the peroxisome proliferator-activated receptor--coactivator-1(PGC-1), the major regulator of mitochondrial content. We also studied the expression of the catalytic A subunit of calcineurin (CnA) both at protein and transcript levels, and mRNA levels of modulatory-calcineurin inhibitor proteins-1 and -2 (MCIP-1, MCIP-2) which are differentially regulated by calcineurin activity and thyroid hormone, respectively. CsA-administration induced a slow-to-fast MHC transition limited to the type IIA isoform, associated with increased oxidative capacities. Hypothyroidism strongly decreased both the expression of fast-MHC isoforms and oxidative capacities. Effects of CsA-administration on muscle phenotype were blocked in conditions of thyroid hormone deficiency. Changes in the oxidative profile were strongly related to PGC-1 changes, and associated with phosphorylation of p38 MAPK. Calcineurin and MCIPs mRNA levels were decreased both by hypothyroidism and CsA, without additive effects. Taken together these results suggest that adult muscle phenotype is primarily under the control of thyroid state. Physiological levels of thyroid hormone are required for the effects of calcineurin inhibition on slow-oxidative muscle phenotype.